An Israeli pharmaceutical company reported record sales for the second quarter of 2008.
Teva Pharmaceutical Industries showed net sales of $2.82 billion, beating analyst expectations by several billion dollars, the Israeli business daily Globes reported.
The record sales were attributed in part to the success of the multiple sclerosis drug Copaxone, which was Israeli researched and produced.
Support the Jewish Telegraphic Agency
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
